tosufloxacin has been researched along with zithromax in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (14.29) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaneko, A; Karakida, K; Katoh, H; Naitoh, H; Sakamoto, H; Sasaki, J; Shiiki, K; Tomita, F; Yamane, N; Yoshida, H | 1 |
Sasaki, J | 1 |
Fukuda, Y; Futakuchi, N; Kamiyama, T; Maekawa, M; Mitsuyama, J; Sugiura, Y; Takahata, M | 1 |
Friedman, H; Yamaguchi, H; Yamamoto, M; Yamamoto, Y; Yasuda, K | 1 |
Akamine, M; Fujita, J; Haranaga, S; Higa, F; Koide, M; Saito, A; Shinzato, T; Tateyama, M; Tohyama, M | 1 |
Akaike, H; Kato, A; Kawai, Y; Kawasaki, K; Kondo, E; Kubo, M; Miyashita, N; Nakano, T; Nishizawa, Y; Ogita, S; Ouchi, K; Saito, A; Tanaka, T; Terada, K; Teranishi, H | 1 |
Aoyagi, H; Ariga, T; Furuyama, H; Hara, K; Hazama, K; Horino, A; Ishiguro, N; Ishizaka, A; Kaiho, M; Kenri, T; Kikuta, H; Koseki, N; Morita, K; Nagano, N; Naito, H; Nakanishi, M; Oba, K; Sasaki, S; Shibata, M; Shida, S; Tabata, Y; Togashi, T; Watanabe, T; Yamanaka, T; Yoshioka, M | 1 |
1 review(s) available for tosufloxacin and zithromax
Article | Year |
---|---|
[Azithromycin in dentistry and oral surgery].
Topics: Anti-Infective Agents; Azithromycin; Bacteria; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Naphthyridines; Periodontal Diseases; Treatment Outcome | 2000 |
2 trial(s) available for tosufloxacin and zithromax
Article | Year |
---|---|
[Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Double-Blind Method; Female; Fluoroquinolones; Humans; Japan; Jaw; Male; Middle Aged; Naphthyridines; Osteitis; Pericoronitis; Periodontitis | 1995 |
Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Child, Preschool; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Infant; Infant, Newborn; Male; Minocycline; Mutation; Mycoplasma pneumoniae; Naphthyridines; Pneumonia, Mycoplasma; RNA, Bacterial; RNA, Ribosomal, 23S; Treatment Outcome | 2013 |
4 other study(ies) available for tosufloxacin and zithromax
Article | Year |
---|---|
[Alteration of antibacterial activity of tosufloxacin and various antibacterial agents against Streptococcus pneumoniae].
Topics: 4-Quinolones; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cephalosporins; Drug Resistance, Bacterial; Fluoroquinolones; Humans; Japan; Naphthyridines; Penicillin Resistance; Streptococcus pneumoniae; Time Factors | 2003 |
Chlamydia pneumoniae resists antibiotics in lymphocytes.
Topics: Animals; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cells, Cultured; Chlamydia Infections; Chlamydophila pneumoniae; Clarithromycin; Female; Fluoroquinolones; Humans; Lymphocytes; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Bacterial | 2003 |
In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
Topics: Animals; Anti-Bacterial Agents; Azithromycin; Cell Line; Colony Count, Microbial; Fluoroquinolones; Legionella; Macrolides; Macrophages; Mice; Microbial Sensitivity Tests; Naphthyridines; Oxazines; Quinolones | 2005 |
Therapeutic efficacy of azithromycin, clarithromycin, minocycline and tosufloxacin against macrolide-resistant and macrolide-sensitive Mycoplasma pneumoniae pneumonia in pediatric patients.
Topics: Adolescent; Anti-Bacterial Agents; Azithromycin; Child; Clarithromycin; Drug Resistance, Bacterial; Female; Fluoroquinolones; Humans; Male; Microbial Sensitivity Tests; Minocycline; Mycoplasma pneumoniae; Naphthyridines; Pneumonia, Mycoplasma; Treatment Outcome | 2017 |